Canopy Growth Corporation vs Abbvie Inc.
CGC vs ABBV — side-by-side comparison from reported financials. CGC leads 1, ABBV leads 8 of 9 comparable metrics.
Canopy Growth Corporation
CGC · Healthcare
$0.84-0.80%Mixed
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | CGC | ABBV |
|---|---|---|
| Price | $0.84 | $276.43 |
| Market cap | $360M | $488B |
| Revenue (TTM) | $285M | $64.4B |
| Revenue growth | -10.9% | +1.8% |
| Net margin | -92.4% | 9.8% |
| Free cash flow | -$69.1M | $18.2B |
| Net cash (debt) | $148M | ($56.2B) |
| 1-year price return | -49.1% | +19.8% |
| P/E | — | 77.4 |
| P/E vs own history (cheap-side %) | — | 23% |
| Dividend yield | — | 2.45% |
| Return on equity | -33% | 96% |
| Altman Z-score | -13.41 | 2.33 |
| CV checks passed | 3 of 9 | 9 of 9 |
| Employees | 1,128 | 57,000 |
Full résumé-style profiles: CGC CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.